attachment
attachment

I have exam tomorrow on this topic can you please help me go through this ...and can you please all the important questions πŸ™

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I've used my library query budget. I have Harper's, Lippincott's, and Basic Medical Biochemistry in the library. Now let me compile a comprehensive exam guide from my strong Biochemistry knowledge base, covering all 14 topics with their weightage. This is a standard Biochemistry Paper 2 syllabus (likely MBBS/BDS level).

πŸ“š Biochemistry Paper 2 - Complete Exam Guide

Total: 151 marks | Exam Tomorrow - High Priority Topics First

PRIORITY ORDER (by marks):

  • πŸ”΄ 13 marks each: Protein & AA Metabolism, Molecular Biology, Molecular Biology Techniques, Heme Metabolism, Organ Function Tests
  • 🟠 10 marks each: Nucleotide Metabolism, Biochemistry of Cancer
  • 🟑 6 marks each: Protein Chemistry, Nucleic Acid Chemistry, Free Radicals & Antioxidants
  • 🟒 5 marks each: Plasma Proteins, Immunology, Clinical Chemistry
  • πŸ”΅ 3 marks: Xenobiotics & Detoxification

πŸ”΄ TOPIC 1: Protein & Amino Acid Metabolism (13 marks)

Most Important Questions:

Q1. Explain the urea cycle. Mention disorders of the urea cycle.
  • Urea cycle occurs in liver (both mitochondria + cytoplasm)
  • Converts toxic NH₃ β†’ urea (excreted in urine)
  • Steps:
    1. NH₃ + COβ‚‚ + 2ATP β†’ Carbamoyl phosphate (enzyme: CPS-I, in mitochondria)
    2. Carbamoyl phosphate + Ornithine β†’ Citrulline (OTC enzyme)
    3. Citrulline β†’ Argininosuccinate (+ Aspartate, ATP)
    4. Argininosuccinate β†’ Arginine + Fumarate
    5. Arginine β†’ Ornithine + Urea (arginase)
  • Disorders: Hyperammonemia - ornithine transcarbamylase deficiency (most common, X-linked)
Q2. Phenylketonuria (PKU) - causes, biochemistry, clinical features, treatment
  • Deficiency of phenylalanine hydroxylase (PAH)
  • Phenylalanine accumulates β†’ phenylpyruvate, phenyllactate in urine
  • Features: intellectual disability, fair skin/hair/eyes, musty odor, seizures
  • Treatment: Low-phenylalanine diet, tetrahydrobiopterin (BH4)
  • Screening: Guthrie test (heel-prick blood spot)
Q3. Transamination and Deamination
  • Transamination: Transfer of -NHβ‚‚ group from AA to Ξ±-keto acid (enzyme: transaminases/aminotransferases, coenzyme: PLP/Pyridoxal phosphate)
    • ALT: Alanine + Ξ±-KG ↔ Pyruvate + Glutamate
    • AST: Aspartate + Ξ±-KG ↔ Oxaloacetate + Glutamate
  • Oxidative deamination: Glutamate β†’ Ξ±-KG + NH₃ (enzyme: Glutamate dehydrogenase, GDH)
Q4. Maple Syrup Urine Disease (MSUD)
  • Deficiency of branched-chain Ξ±-keto acid dehydrogenase
  • Branched chain AAs accumulate: Leucine, Isoleucine, Valine
  • Features: Sweet maple syrup odor of urine, encephalopathy, death if untreated
  • Treatment: Diet restricted in branched-chain AAs
Q5. One carbon metabolism / Transmethylation
  • SAM (S-Adenosylmethionine) = universal methyl donor
  • Homocysteine β†’ Methionine (requires folate + Vit B12)
  • Homocystinuria: CBS enzyme deficiency β†’ homocysteine accumulates β†’ thromboembolism, Marfanoid habitus, lens dislocation, intellectual disability
Q6. Catecholamine synthesis
  • Tyrosine β†’ DOPA β†’ Dopamine β†’ Norepinephrine β†’ Epinephrine
  • Rate-limiting enzyme: Tyrosine hydroxylase
  • Degradation by MAO (monoamine oxidase) and COMT

πŸ”΄ TOPIC 2: Molecular Biology (13 marks)

Most Important Questions:

Q1. DNA Replication - explain the process and enzymes involved
  • Semi-conservative replication (Watson-Crick)
  • Key enzymes:
    EnzymeFunction
    HelicaseUnwinds double helix
    PrimaseSynthesizes RNA primer
    DNA Pol IIIMain replicating enzyme (prokaryotes)
    DNA Pol IRemoves primers, fills gaps
    DNA LigaseJoins Okazaki fragments
    TopoisomeraseRelieves torsional stress
  • Leading strand: continuous synthesis
  • Lagging strand: discontinuous (Okazaki fragments)
Q2. Transcription - process and types of RNA
  • Template strand = antisense strand; coding strand = sense strand
  • RNA Polymerase (no primer needed)
  • 3 types of RNA:
    • mRNA - carries genetic info
    • tRNA - anticodon, carries AA (clover-leaf structure)
    • rRNA - structural component of ribosome (most abundant)
  • Post-transcriptional modifications of mRNA: 5' capping, 3' poly-A tail, splicing of introns
Q3. Translation - protein synthesis
  • Codons: triplet code; AUG = start codon (Met)
  • Stop codons: UAA, UAG, UGA
  • Ribosomes: A site (aminoacyl), P site (peptidyl), E site (exit)
  • Initiation β†’ Elongation β†’ Termination
  • Wobble hypothesis (Crick): 3rd base of codon can mismatch
Q4. Mutations - types and consequences
  • Point mutations: Missense (wrong AA), Nonsense (stop codon), Silent (same AA)
  • Frameshift: insertion/deletion β†’ shifts reading frame
  • Transition: purine↔purine or pyrimidine↔pyrimidine
  • Transversion: purine↔pyrimidine
  • Clinical: Sickle cell anemia = missense mutation (Gluβ†’Val, codon 6, Ξ²-globin)
Q5. Regulation of Gene Expression
  • Lac operon (prokaryote model): Repressor model
    • Structural genes: lacZ (Ξ²-galactosidase), lacY (permease), lacA (transacetylase)
    • When lactose present: inducer binds repressor β†’ repressor leaves operator β†’ genes expressed
  • Eukaryotes: Enhancers, silencers, transcription factors, methylation, histones

πŸ”΄ TOPIC 3: Molecular Biology Techniques (13 marks)

Most Important Questions:

Q1. PCR (Polymerase Chain Reaction) - principle, steps, applications
  • Amplifies specific DNA sequences
  • 3 steps (repeated ~30 cycles):
    1. Denaturation (~94Β°C): strands separate
    2. Annealing (~55Β°C): primers bind template
    3. Extension (~72Β°C): Taq polymerase extends
  • Result: Exponential amplification (2ⁿ copies)
  • Applications: Diagnosis of infections (HIV, TB), genetic diseases, forensics, paternity testing, COVID-19 testing
Q2. Southern, Northern, and Western Blotting
TechniqueDetectsProbe Used
SouthernDNALabeled DNA/RNA
NorthernRNA (mRNA)Labeled DNA/RNA
WesternProteinLabeled antibody
EasternPost-translational modificationsSpecific ligand
  • General steps: Gel electrophoresis β†’ Transfer to nitrocellulose membrane β†’ Hybridization with probe β†’ Detection
Q3. RFLP (Restriction Fragment Length Polymorphism)
  • Restriction endonucleases cut DNA at specific palindromic sequences
  • Differences in fragment lengths = genetic polymorphisms
  • Used in: Genetic fingerprinting, diagnosis of sickle cell disease, paternity testing
Q4. DNA Sequencing (Sanger's method)
  • Uses chain-terminating ddNTPs (dideoxynucleotides)
  • Four reactions with ddATP, ddTTP, ddGTP, ddCTP
  • Gel electrophoresis separates fragments β†’ sequence read
Q5. Recombinant DNA Technology / Gene Cloning
  • Steps: Isolation of gene β†’ Restriction enzyme cuts β†’ Ligation into vector (plasmid) β†’ Transformation into host β†’ Selection β†’ Expression
  • Vectors: Plasmids, bacteriophages, cosmids, YACs
  • Applications: Insulin production (1st recombinant protein), HGH, erythropoietin, Hepatitis B vaccine
Q6. CRISPR-Cas9
  • Gene editing tool: guide RNA directs Cas9 nuclease to specific DNA sequence β†’ cuts DNA
  • Used for gene therapy, cancer research

πŸ”΄ TOPIC 4: Heme Metabolism (13 marks)

Most Important Questions:

Q1. Synthesis of Heme - steps and enzymes
  • Occurs in: Liver (for cytochromes) and Bone marrow (for Hb)
  • Steps:
    1. Glycine + Succinyl CoA β†’ Ξ΄-ALA (enzyme: ALA synthase - rate-limiting, requires PLP/B6)
    2. 2 ALA β†’ Porphobilinogen (PBG) - ALA dehydratase (inhibited by lead)
    3. 4 PBG β†’ Hydroxymethylbilane β†’ Uroporphyrinogen III β†’ Coproporphyrinogen III β†’ Protoporphyrin IX
    4. Protoporphyrin IX + Fe²⁺ β†’ Heme (enzyme: Ferrochelatase, inhibited by lead)
Q2. Porphyrias - classification and clinical features
  • Acute Intermittent Porphyria (AIP): PBG deaminase deficiency; abdominal pain, neuropsychiatric symptoms, port-wine urine; No photosensitivity
  • Porphyria Cutanea Tarda (PCT): Uroporphyrinogen decarboxylase deficiency; most common porphyria; photosensitivity, blistering skin
  • Congenital Erythropoietic Porphyria: Uroporphyrinogen III cosynthase deficiency; red urine, severe photosensitivity, hemolytic anemia
Q3. Heme Catabolism / Bilirubin Metabolism
  • RBC destruction β†’ Heme β†’ Biliverdin (by Heme oxygenase) β†’ Unconjugated bilirubin (UCB)
  • UCB is insoluble, carried in blood bound to albumin
  • In liver: UCB + glucuronic acid (UGT enzyme) β†’ Conjugated bilirubin (CB) = direct bilirubin
  • CB excreted in bile β†’ intestine β†’ Urobilinogen β†’ Stercobilin (feces, brown color) + Urobilin (urine, yellow)
Q4. Jaundice - types (MUST KNOW)
FeaturePre-hepaticHepaticPost-hepatic
CauseHemolysisHepatitis, cirrhosisBile duct obstruction
UCB↑↑↑Normal
CBNormal↑↑↑
Urine bilirubinAbsentPresentPresent
Urobilinogen↑↑↓Absent
Stool colorDarkPaleClay-colored
ALPNormal↑↑↑
Q5. Neonatal Jaundice / Kernicterus
  • Physiological: Days 2-4 due to immature liver UGT
  • Hemolytic disease: Rh incompatibility β†’ severe UCB
  • Kernicterus: UCB deposits in basal ganglia β†’ neurological damage
  • Treatment: Phototherapy (converts UCB to lumirubin, water-soluble)
Q6. Lead Poisoning - effect on heme synthesis
  • Inhibits: ALA dehydratase and Ferrochelatase
  • ALA and Coproporphyrin III accumulate in urine
  • Features: Basophilic stippling of RBCs, microcytic hypochromic anemia, Burton's lines (gums), encephalopathy
  • Treatment: Chelation therapy (DMSA, EDTA)

πŸ”΄ TOPIC 5: Organ Function Tests (13 marks)

Most Important Questions:

Q1. Liver Function Tests (LFTs)
TestNormal ValueClinical Significance
Total Bilirubin0.3-1.2 mg/dL↑ in jaundice
Direct bilirubin<0.3 mg/dL↑ in obstructive/hepatic
ALT (SGPT)7-40 U/LMost specific for liver damage
AST (SGOT)10-40 U/LLiver, heart, muscle
ALP44-147 U/L↑↑ in cholestasis
GGT9-48 U/LAlcohol intake, cholestasis
Albumin3.5-5 g/dL↓ in chronic liver disease
PT/INR↑ in liver failure
Total protein6-8 g/dL
Q2. Kidney Function Tests (RFTs)
  • Blood Urea Nitrogen (BUN): 7-20 mg/dL; ↑ in renal failure, dehydration
  • Serum Creatinine: 0.6-1.2 mg/dL; best index of GFR; not affected by diet
  • GFR: Normal ~125 mL/min; CKD if <60 mL/min for >3 months
  • Uric acid: End product of purine catabolism; ↑ in gout
  • Creatinine clearance = [U Γ— V] / P (gold standard for GFR estimation)
  • Urine: Proteinuria, hematuria, casts in nephritis
Q3. Thyroid Function Tests
  • TSH: Most sensitive test (0.4-4.0 mIU/L)
  • Free T4 (fT4) and Free T3 (fT3)
  • Hypothyroid: ↑TSH, ↓fT4 | Hyperthyroid: ↓TSH, ↑fT4
  • T3 is metabolically more active, T4 is converted to T3 in tissues
Q4. Cardiac Markers
MarkerRisesPeaksReturns to Normal
Troponin I/T3-6 hrs14-18 hrs5-10 days
CK-MB4-8 hrs18-24 hrs2-3 days
Myoglobin1-2 hrs4-8 hrs24 hrs
LDH12-24 hrs2-4 days7-10 days
  • Troponin = most specific and sensitive for myocardial damage

🟠 TOPIC 6: Nucleotide Metabolism (10 marks)

Most Important Questions:

Q1. De novo synthesis of purine nucleotides
  • Purine ring is built atom by atom on PRPP (phosphoribosyl pyrophosphate)
  • Key reactions: 10 steps; end product = IMP β†’ AMP or GMP
  • Rate-limiting enzyme: PRPP amidotransferase (inhibited by AMP, GMP - feedback)
  • Key donors: Glutamine (N), glycine, formate (C10-THF), CO2, aspartate
Q2. Salvage pathway of purines
  • Recycles free purine bases β†’ nucleotides
  • HGPRT (Hypoxanthine-Guanine Phosphoribosyl Transferase) - converts hypoxanthine β†’ IMP, guanine β†’ GMP
  • Lesch-Nyhan syndrome: HGPRT deficiency β†’ hypoxanthine not salvaged β†’ excess uric acid production β†’ gout + neurological features (self-mutilation, choreoathetosis, intellectual disability)
Q3. Purine catabolism / Gout
  • Purines β†’ Hypoxanthine β†’ Xanthine β†’ Uric Acid (enzyme: Xanthine oxidase)
  • Gout: Uric acid crystals deposit in joints (esp. big toe = podagra), tophi, kidney stones
  • Treatment: Allopurinol (xanthine oxidase inhibitor); Colchicine (acute attack)
Q4. De novo synthesis of pyrimidines
  • Ring is first synthesized, then attached to ribose
  • CAD enzyme (Carbamoyl phosphate synthetase II, Aspartate transcarbamylase, Dihydroorotase) - rate-limiting complex
  • End product: UMP β†’ UDP β†’ UTP β†’ CTP
  • Orotic aciduria: Deficiency of UMP synthase β†’ orotic acid in urine, megaloblastic anemia

🟠 TOPIC 7: Biochemistry of Cancer (10 marks)

Most Important Questions:

Q1. Oncogenes and Tumor Suppressor Genes
  • Proto-oncogenes β†’ Oncogenes when mutated (accelerators of cell growth)
    • Examples: ras (most commonly mutated in cancer), myc, her2/neu, bcr-abl
    • bcr-abl: Philadelphia chromosome in CML; target of Imatinib
  • Tumor suppressor genes = brakes for cell growth
    • p53 (guardian of the genome): mutated in >50% of cancers; triggers apoptosis at G1
    • Rb (retinoblastoma protein): mutated in retinoblastoma, osteosarcoma
Q2. Warburg Effect
  • Cancer cells preferentially use aerobic glycolysis (glucose β†’ lactate) even when O2 is available
  • Reason: Need for biosynthetic precursors (pentose phosphate pathway, lipid synthesis)
  • PET scan exploits this: ¹⁸FDG (glucose analog) taken up more by cancer cells
Q3. Tumor markers
MarkerCancer
AFP (Ξ±-fetoprotein)Hepatocellular carcinoma, germ cell tumors
CEA (Carcinoembryonic Ag)Colorectal, pancreatic, lung
PSAProstate cancer
CA-125Ovarian cancer
CA 19-9Pancreatic cancer
Ξ²-hCGChoriocarcinoma, testicular tumors
S-100Melanoma
BRCA1/2Breast/ovarian cancer risk
Q4. Cell cycle and cancer
  • G1 β†’ S β†’ G2 β†’ M phases
  • Cyclins and CDKs drive progression
  • Checkpoints: G1/S (Rb-E2F), G2/M (p53)
  • Apoptosis: Intrinsic (Bcl-2/Bax, mitochondria) and extrinsic (death receptor, FasL) pathways

🟑 TOPIC 8: Protein Chemistry (6 marks)

Most Important Questions:

Q1. Structure of Proteins - 4 levels
  • Primary: AA sequence (peptide bonds)
  • Secondary: Ξ±-helix (H-bonds within same chain, 3.6 AA/turn), Ξ²-pleated sheet (H-bonds between adjacent chains)
  • Tertiary: 3D folding; stabilized by disulfide bonds, hydrophobic interactions, H-bonds, ionic bonds
  • Quaternary: Multiple subunits (e.g., Hb = 2Ξ± + 2Ξ²)
Q2. Denaturation of proteins
  • Loss of 3D structure without breaking peptide bonds
  • Agents: Heat, strong acids/bases, organic solvents, heavy metals, urea
  • Renaturation = reversible denaturation
Q3. Sickle Cell Anemia - molecular defect
  • Missense mutation: codon 6 of Ξ²-globin: GAG β†’ GTG (Glu β†’ Val)
  • In deoxygenated state: HbS polymerizes β†’ sickle-shaped RBCs
  • Features: Chronic hemolytic anemia, vaso-occlusive crises, splenomegaly, stroke
  • HbS in sickle cell: Hydrophobic valine creates sticky patch

🟑 TOPIC 9: Nucleic Acid Chemistry (6 marks)

Most Important Questions:

Q1. Structure of DNA (Watson-Crick model)
  • Double helix, antiparallel strands
  • B-DNA: right-handed, 10 bp/turn, most common physiological form
  • Base pairing: A=T (2 H-bonds), G≑C (3 H-bonds)
  • Backbone: Sugar (deoxyribose) - Phosphate
  • Purines: Adenine, Guanine | Pyrimidines: Cytosine, Thymine (DNA), Uracil (RNA)
  • Chargaff's rules: A=T, G=C; %A+G = %T+C (50% purines, 50% pyrimidines)
Q2. Types of RNA and their functions
RNAFunction
mRNACarries genetic code from DNA to ribosome
tRNAAdaptor molecule; anticodon matches codon
rRNAStructural/catalytic component of ribosome
snRNASplicing of pre-mRNA
miRNA/siRNAGene silencing, post-transcriptional regulation
hnRNAPrecursor mRNA (primary transcript)

🟑 TOPIC 10: Free Radicals and Antioxidants (6 marks)

Most Important Questions:

Q1. Free radicals - types and damage
  • Reactive Oxygen Species (ROS): Superoxide (O₂‒⁻), Hydroxyl (β€’OH), Peroxyl, Hβ‚‚Oβ‚‚
  • Generated by: Mitochondrial electron transport, phagocytosis, radiation, smoking
  • Damage: Lipid peroxidation (membrane damage), DNA strand breaks, protein oxidation
Q2. Antioxidant defense mechanisms
  • Enzymatic:
    • SOD (Superoxide dismutase): O₂‒⁻ β†’ Hβ‚‚Oβ‚‚ (contains Mn, Cu, Zn)
    • Catalase: Hβ‚‚Oβ‚‚ β†’ Hβ‚‚O + Oβ‚‚ (in peroxisomes)
    • Glutathione peroxidase: Hβ‚‚Oβ‚‚ + GSH β†’ GSSG (requires Se)
  • Non-enzymatic: Vit C, Vit E (lipid-soluble, most important), Ξ²-carotene, uric acid, albumin
Q3. Role in disease
  • ROS β†’ atherosclerosis (LDL oxidation), aging, cancer, reperfusion injury, diabetes complications

🟒 TOPIC 11: Plasma Proteins (5 marks)

Most Important Questions:

Q1. Classification and functions of plasma proteins
  • Albumin (most abundant, 60%): Transport (bilirubin, FFA, drugs, Ca²⁺), maintain colloid osmotic pressure, buffer
  • Globulins: Ξ±1, Ξ±2, Ξ², Ξ³
    • Ξ±1: Ξ±1-antitrypsin (protease inhibitor), orosomucoid
    • Ξ±2: Haptoglobin (binds free Hb), ceruloplasmin (copper transport), Ξ±2-macroglobulin
    • Ξ²: Transferrin (iron transport), fibronectin, complement
    • Ξ³: Immunoglobulins (IgG, IgA, IgM, IgD, IgE)
  • Fibrinogen: Coagulation; converted to fibrin by thrombin
Q2. Acute Phase Proteins
  • Rise rapidly in inflammation/infection
  • Positive: CRP (best marker), fibrinogen, ferritin, haptoglobin, Ξ±1-antitrypsin, SAA
  • Negative: Albumin, transferrin ↓ (diverted resources to synthesis of positive APP)
  • CRP uses: monitor inflammation, infection, assess response to therapy

🟒 TOPIC 12: Immunology (5 marks)

Most Important Questions:

Q1. Immunoglobulins - structure and types
  • Basic unit: 2 heavy chains + 2 light chains (ΞΊ or Ξ») linked by disulfide bonds
  • Fab region: antigen binding | Fc region: complement activation, receptor binding | Ig | Special feature | |----|----------------| | IgG | Most abundant; only one crossing placenta; secondary response | | IgM | Pentamer; first produced in primary response; largest | | IgA | Secretory (saliva, tears, breast milk, gut); dimer | | IgE | Allergy, helminth defense; triggers mast cell degranulation | | IgD | B cell surface receptor |
Q2. Complement system
  • Classical pathway: Activated by Ag-Ab complex (IgM/IgG)
  • Alternate pathway: Activated by bacterial surfaces, LPS
  • Lectin pathway: MBL binds mannose on pathogens
  • Final: MAC (Membrane Attack Complex) C5b-9 β†’ lyses cells

🟒 TOPIC 13: Clinical Chemistry (5 marks)

Most Important Questions:

Q1. Blood glucose and diabetes
  • Fasting blood glucose: 70-100 mg/dL normal
  • Impaired fasting: 100-125 mg/dL; Diabetes: β‰₯126 mg/dL (fasting, confirmed twice)
  • 2-hr OGTT: β‰₯200 mg/dL = diabetes
  • HbA1c: Best measure of long-term glycemic control (3 months); β‰₯6.5% = diabetes
  • Glycosylation: Glucose attaches to N-terminal valine of Hb non-enzymatically
Q2. Lipid profile
  • Total cholesterol: <200 mg/dL desirable
  • LDL ("bad"): <100 mg/dL optimal; ↑ risk of atherosclerosis
  • HDL ("good"): >60 mg/dL protective
  • Triglycerides: <150 mg/dL normal
  • Friedewald formula: LDL = Total cholesterol - HDL - (TG/5)

πŸ”΅ TOPIC 14: Xenobiotics and Detoxification (3 marks)

Most Important Questions:

Q1. Phases of drug metabolism (Biotransformation)
  • Phase I (Functionalization): Oxidation, reduction, hydrolysis β†’ adds/exposes functional groups (-OH, -NHβ‚‚)
    • Enzymes: Cytochrome P450 (CYP) enzymes in ER of liver
    • Products: May be more or less toxic
  • Phase II (Conjugation): Adds polar group β†’ makes highly water-soluble for excretion
    • Glucuronidation (UDP-glucuronosyltransferase - most important)
    • Sulfation, acetylation, methylation, glutathione conjugation
  • Phase III: Transporters (efflux pumps, P-glycoprotein) export conjugated products

πŸ“ RAPID REVISION - KEY MNEMONICS

MnemonicTopic
"A Pee Gee Cup COF"Urea cycle: Arginine, Phosphate, Glycine β†’ Carbamoyl phosphate, Ornithine, Fumarate
"TACT"Blotting: T=Transfer, A=Antibody, C=Color/detect
"GCAT for DNA, GCAU for RNA"Nucleic acids
"Lead poisons ALA-D and Ferro"Lead inhibits ALA dehydratase and Ferrochelatase
"PKU = Phe Can't Undergo (hydroxylation)"PKU
"MUGSY"Tumor suppressor genes: Menin, p53/Rb, BRCA

⭐ HIGHEST-YIELD 1-LINERS FOR TOMORROW

  1. Most common porphyria: Porphyria Cutanea Tarda (PCT)
  2. Rate-limiting enzyme of heme synthesis: ALA synthase
  3. Rate-limiting enzyme of urea cycle: CPS-I (Carbamoyl Phosphate Synthetase-I)
  4. Universal methyl donor: SAM (S-Adenosylmethionine)
  5. Lesch-Nyhan = HGPRT deficiency β†’ Self-mutilation + gout
  6. Sickle cell = Glu β†’ Val (codon 6, Ξ²-globin)
  7. Most specific cardiac marker: Troponin I/T
  8. Most common oncogene mutated in cancer: ras
  9. Guardian of the genome: p53
  10. Most abundant plasma protein: Albumin
  11. Phototherapy treats neonatal jaundice by converting UCB β†’ lumirubin
  12. Only Ig crossing placenta: IgG
  13. PCR = Taq polymerase (heat-stable, from Thermus aquaticus)
  14. Guthrie test = newborn screening for PKU
  15. Allopurinol = xanthine oxidase inhibitor β†’ treats gout

Good luck on your exam tomorrow! πŸ€ Focus your revision energy in this order:
  1. Heme metabolism (full pathway + porphyrias + jaundice table)
  2. Molecular biology (central dogma + lac operon)
  3. Molecular biology techniques (PCR + blotting table)
  4. Protein/AA metabolism (urea cycle + PKU + amino acidopathies)
  5. Organ function tests (LFTs + cardiac markers)
These 5 topics = 65 marks out of 151. Master them and you're more than halfway there! πŸ’ͺ
This is a shared conversation. Sign in to Orris to start your own chat.